47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | -0,1 | -0,2 | -231,9 |
Gross profit (loss) | 0,1 | 1,2 | 4,6 | 282,3 |
EBITDA | -0,1 | -0,1 | -0,2 | -231,8 |
Short time liabilities | 1,2 | 0,5 | 0,5 | 17,4 |
Other operating costs | 0 | 0 | 0 | 65,3 |
Equity capital | 3,2 | 4,4 | 7,8 | 76,6 |
Operating profit (EBIT) | -0,1 | -0,1 | -0,3 | -219,3 |
Assets | 4,4 | 4,9 | 8,4 | 70,5 |
Net profit (loss) | 0 | 1,2 | 4,6 | 274,2 |
Cash | 0 | 0 | 0 | -39,3 |
Net income from sale | 2,7 | 3,1 | 3 | -3 |
Liabilities and provisions for liabilities | 1,2 | 0,5 | 0,6 | 15,9 |
Working assets | 0,3 | 0,8 | 4,3 | 415,8 |
Other income costs | 0 | 0 | 0 | -54,7 |
Depreciation | 0 | 0 | 0 | 56,2 |
% | % | % | p.p. | |
Profitability of capital | 0,8 | 27,9 | 59,2 | 31,3 |
Equity capital to total assets | 73,3 | 90,1 | 93,2 | 3,1 |
Gross profit margin | 2,9 | 38,7 | 152,5 | 113,8 |
EBITDA Margin | -4,4 | -2,3 | -8 | -5,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 154 | 53 | 64 | 11 |
Current financial liquidity indicator | 0.295428603887558 | 1.8381571769714355 | 8.075260162353516 | 6,3 |
Net dept to EBITDA | 0.02881699800491333 | 0.07010453939437866 | 0.012828322127461433 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane